What does OXYSPHAIR do?

OXYSPHAIR is a wholesaler in Courcelles. Private Limited, started on 23 June 1999, 1 establishment.

What is the address of OXYSPHAIR?

The registered office of OXYSPHAIR is located at Rue de Charleroi(CO) 4, 6180 Courcelles.

Is OXYSPHAIR still active?

Yes. According to the CBE (30 October 2026) OXYSPHAIR is active, legal situation “Normale toestand”, started on 23 June 1999.

Is OXYSPHAIR registered on Peppol?

Yes, OXYSPHAIR is registered on the Peppol network with ID 0208:0466323738.

What is the enterprise number of OXYSPHAIR?

The enterprise number of OXYSPHAIR is BE0466323738.

When was OXYSPHAIR founded?

OXYSPHAIR was founded on 23 June 1999.

Who are the directors of OXYSPHAIR?

According to the 2025 annual accounts, the directors of OXYSPHAIR are: NIK DE CORTE BV, IBPM SRL.

Is OXYSPHAIR a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 23 June 1999; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did OXYSPHAIR make in 2025?

OXYSPHAIR posted a profit after taxes of € 1,958,233 in financial year 2025.

What is the revenue of OXYSPHAIR?

In its most recent annual accounts (2025), OXYSPHAIR reported revenue of € 15,885,223.

How much does an employee at OXYSPHAIR earn?

The average wage cost per full-time employee at OXYSPHAIR was € 82,400 in 2025: staff costs of € 2.6 million for 31.1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does OXYSPHAIR have?

According to the 2025 annual accounts, OXYSPHAIR has 31.1 full-time equivalents (FTE).

Does OXYSPHAIR have a website?

Yes, OXYSPHAIR has a website at oxysphair.be.

OXYSPHAIR (Private Limited) - Courcelles - BE0466323738

Dossier OXYSPHAIR, printed on 30 October 2026 from databakkes.be/en/0466323738/oxysphair. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Figures corrected NBB

Corrected annual account filed for 2024.

Financials

Financial year 2025

OXYSPHAIR from Courcelles, company number BE0466323738, closed financial year 2025 with a result of € 2 million after tax. For that financial year OXYSPHAIR recorded revenue of € 15.9 million and equity of € 4.9 million. Compared with financial year 2024, the result moved from € 1.5 million to € 2 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 18, 2026.

What it is worth Growing

€ 4.9 million

▲ 13% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 2 million

▲ 33% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 1.1 million

▲ 11% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 1.4 million paid out

71 % of the profit went to the shareholders, mostly to Messer Medical Home Care Holding Gmbh (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

31.1

▲ 2.7 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost Staff costs are payroll only. Director pay sits with services and miscellaneous goods: € 2.2 million in 2025, together with rent, insurance, accountants and other services. The accounts do not split that further.

€ 2.6 million

▲ 1% vs 2024

€ 82,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 520,060

▼ 10% vs 2024

Of which on lease € 488,339.

Debts at end 2025

Bank debt ≈ 8 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 789,570

▲ 39% vs 2024

€ 91,496 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.

Owed to suppliers

€ 2.1 million

▲ 10% vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 81 days on average.

Taxes and wages

€ 548,676

▲ 17% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 10,848,572 Revenue 2022: € 10,848,572 First fiscal year in the series	€ 12,468,162 Revenue 2023: € 12,468,162 ▲ 15% vs 2022 (€ 10,848,572) Favourable step	€ 14,039,983 Revenue 2024: € 14,039,983 ▲ 13% vs 2023 (€ 12,468,162) Favourable step	€ 15,885,223 Revenue 2025: € 15,885,223 ▲ 13% vs 2024 (€ 14,039,983) Favourable step	▲ 13%
Profit after taxes	€ 1,111,234 Profit after taxes 2022: € 1,111,234 First fiscal year in the series	€ 1,445,555 Profit after taxes 2023: € 1,445,555 ▲ 30% vs 2022 (€ 1,111,234) Favourable step	€ 1,470,460 Profit after taxes 2024: € 1,470,460 ▲ 2% vs 2023 (€ 1,445,555) Favourable step	€ 1,958,233 Profit after taxes 2025: € 1,958,233 ▲ 33% vs 2024 (€ 1,470,460) Favourable step	▲ 33%
Equity	€ 3,866,367 Equity 2022: € 3,866,367 First fiscal year in the series	€ 4,255,306 Equity 2023: € 4,255,306 ▲ 10% vs 2022 (€ 3,866,367) Favourable step	€ 4,369,348 Equity 2024: € 4,369,348 ▲ 3% vs 2023 (€ 4,255,306) Favourable step	€ 4,921,845 Equity 2025: € 4,921,845 ▲ 13% vs 2024 (€ 4,369,348) Favourable step	▲ 13%
Total debts	€ 3,479,785 Total debts 2022: € 3,479,785 First fiscal year in the series	€ 3,853,803 Total debts 2023: € 3,853,803 ▲ 11% vs 2022 (€ 3,479,785) Unfavourable step	€ 4,303,560 Total debts 2024: € 4,303,560 ▲ 12% vs 2023 (€ 3,853,803) Unfavourable step	€ 4,850,556 Total debts 2025: € 4,850,556 ▲ 13% vs 2024 (€ 4,303,560) Unfavourable step	▲ 13%
Cash	€ 959,175 Cash 2022: € 959,175 First fiscal year in the series	€ 723,917 Cash 2023: € 723,917 ▼ 25% vs 2022 (€ 959,175) Unfavourable step	€ 950,319 Cash 2024: € 950,319 ▲ 31% vs 2023 (€ 723,917) Favourable step	€ 1,055,645 Cash 2025: € 1,055,645 ▲ 11% vs 2024 (€ 950,319) Favourable step	▲ 11%
Land & buildings	€ 33,654 Land & buildings 2022: € 33,654 First fiscal year in the series	€ 30,562 Land & buildings 2023: € 30,562 ▼ 9% vs 2022 (€ 33,654) Unchanged	€ 27,470 Land & buildings 2024: € 27,470 ▼ 10% vs 2023 (€ 30,562) Unchanged	€ 394,869 Land & buildings 2025: € 394,869 ▲ € 367,399 vs 2024 (€ 27,470) Unchanged	▲ € 367,399
Retained profit	€ 2,625,895 Retained profit 2022: € 2,625,895 First fiscal year in the series	€ 3,020,150 Retained profit 2023: € 3,020,150 ▲ 15% vs 2022 (€ 2,625,895) Favourable step	€ 3,136,592 Retained profit 2024: € 3,136,592 ▲ 4% vs 2023 (€ 3,020,150) Favourable step	€ 3,690,603 Retained profit 2025: € 3,690,603 ▲ 18% vs 2024 (€ 3,136,592) Favourable step	▲ 18%
Dividend	€ 1,000,000 Dividend 2022: € 1,000,000 First fiscal year in the series	€ 1,000,000 Dividend 2023: € 1,000,000 Unchanged (€ 1,000,000) Unchanged	€ 1,300,000 Dividend 2024: € 1,300,000 ▲ 30% vs 2023 (€ 1,000,000) Unchanged	€ 1,400,000 Dividend 2025: € 1,400,000 ▲ 8% vs 2024 (€ 1,300,000) Unchanged	▲ 8%
Bank debt	€ 684,716 Bank debt 2022: € 684,716 First fiscal year in the series	€ 618,763 Bank debt 2023: € 618,763 ▼ 10% vs 2022 (€ 684,716) Favourable step	€ 569,551 Bank debt 2024: € 569,551 ▼ 8% vs 2023 (€ 618,763) Favourable step	€ 789,570 Bank debt 2025: € 789,570 ▲ 39% vs 2024 (€ 569,551) Unfavourable step	▲ 39%
Balance sheet total	€ 7,427,352 Balance sheet total 2022: € 7,427,352 First fiscal year in the series	€ 8,171,109 Balance sheet total 2023: € 8,171,109 ▲ 10% vs 2022 (€ 7,427,352) Unchanged	€ 8,672,909 Balance sheet total 2024: € 8,672,909 ▲ 6% vs 2023 (€ 8,171,109) Unchanged	€ 9,792,401 Balance sheet total 2025: € 9,792,401 ▲ 13% vs 2024 (€ 8,672,909) Unchanged	▲ 13%
Employees (FTE)	28.1 Employees (FTE) 2022: 28.1 First fiscal year in the series	27.8 Employees (FTE) 2023: 27.8 ▼ 0.3 vs 2022 (28.1) Unchanged	28.4 Employees (FTE) 2024: 28.4 ▲ 0.6 vs 2023 (27.8) Unchanged	31.1 Employees (FTE) 2025: 31.1 ▲ 2.7 vs 2024 (28.4) Unchanged	▲ 2.7

Key figures of OXYSPHAIR, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to OXYSPHAIR?

What happened at OXYSPHAIR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 18, 2026 New annual accounts for financial year 2025: profit of € 2 million (▲ 33% vs 2024). Source: NBB ↗
2020 NIK DE CORTE BV became a director. NBB
2020 IBPM SRL became a director. NBB
Mar 12, 2002 New establishment in Courcelles. KBO
Jun 23, 1999 Start of the company according to the CBE. KBO

In short

From € 1.1 million profit in 2022 to € 2 million profit in 2025.

Paid € 2.2 million in corporate taxes since 2022.

Best year ever: 2025, with € 2 million profit.

Paid out € 4.7 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Messer Medical Home Care Holding Gmbh 100%

OXYSPHAIR

Behind OXYSPHAIR are NIK DE CORTE BV and IBPM SRL. The shares are held by Messer Medical Home Care Holding Gmbh (100%).

Directors

According to the 2025 annual accounts

NIK DE CORTE BV

Director · represented by Nik De Corte

since 2020

IBPM SRL

Director · represented by Peter Van Draege

since 2020

Shareholders

Messer Medical Home Care Holding Gmbh

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de Charleroi(CO) 4

6180 Courcelles

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS oxysphair.be

Canonical: https://www.oxysphair.be/

Technologies

CalendlyContact Form 7DiviFont AwesomeGoogle FontsGoogle Tag ManagerMasonryNginxPHPPostHogSwiperWPMLWooCommerceWordPressYoast SEOjQueryjQuery UIlazysizesreCAPTCHA

Hosting & Email

Email provider

Microsoft 365

Hosting

VERIXI, BE

DNS

OVH DNS

Website info

HTTPS Ja

Languages FR

Features

Webshop Booking system Ads

Security

✓ HTTPS

✓ SPF

✗ DMARC

Details

Company number

0466.323.738

VAT number

BE 0466.323.738

Registered office

Rue de Charleroi(CO) 4, 6180 Courcelles

Names & denominations

OXYSPHAIR

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

23 June 1999

Peppol

Active · Active since 27 Mar 2026

Contact

oxysphair.be

Activities · NACE

Groothandel in farmaceutische en medische artikelen

Groothandel in farmaceutische producten

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel in medische en orthopedische artikelen

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

Verhuur en lease van medisch en paramedisch materieel

Verhuur van medisch en paramedisch materieel

View on CBE Public ↗ Annual accounts (NBB) ↗

OXYSPHAIR

Warning lights

Financials

What happened to OXYSPHAIR?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Website

Technologies

Hosting & Email

Website info

Features

Security

Details

Frequently asked questions